Compare BLMN & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLMN | CTKB |
|---|---|---|
| Founded | 1988 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 559.9M | 652.1M |
| IPO Year | 2012 | 2021 |
| Metric | BLMN | CTKB |
|---|---|---|
| Price | $5.60 | $4.22 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $8.33 | $5.70 |
| AVG Volume (30 Days) | ★ 2.8M | 658.1K |
| Earning Date | 05-28-2026 | 05-20-2026 |
| Dividend Yield | ★ 7.49% | N/A |
| EPS Growth | ★ 106.71 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $4,213,346,000.00 | $193,015,000.00 |
| Revenue This Year | $2.15 | $5.02 |
| Revenue Next Year | $1.78 | $7.89 |
| P/E Ratio | $59.85 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $5.60 | $2.37 |
| 52 Week High | $10.70 | $6.18 |
| Indicator | BLMN | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 38.21 | 33.16 |
| Support Level | N/A | $4.00 |
| Resistance Level | $7.53 | $4.26 |
| Average True Range (ATR) | 0.46 | 0.21 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 7.21 | 21.43 |
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabba's. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S., while restaurants operating outside the U.S. are included in the international segment.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.